AKTS is Aktis Oncology, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $27.05. Market cap: $1.50B. Capital Quality Rank: 27/100 — Capital destroyer.
Stock snapshot
| Price | $27.05 |
| Market cap | $1.50B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 27 / 100 · Capital destroyer |
| Revenue CAGR (3y) | 60.5% |
| Shareholder buyback yield | -28.58% |
| Altman Z-score zone | Distress |
About AKTS
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.
Related non-dividend companies
Other non-dividend stocks investors research alongside AKTS. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is AKTS's current stock price?
AKTS (Aktis Oncology, Inc.) is currently trading at $27.05.
Does AKTS pay a dividend?
AKTS (Aktis Oncology, Inc.) does not currently pay a regular dividend.
What is AKTS's Capital Quality Rank?
AKTS has a Capital Quality Rank of 27/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track AKTS in DiviDrip
Add AKTS to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search AKTS and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.